GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut. Show more
Location: North Tower, Stamford, CT, 06902, United States | Website: https://www.genedx.com | Industry: Diagnostics & Research | Sector: Healthcare
Market Cap
4.842B
52 Wk Range
$55.17 - $167.72
Previous Close
$167.52
Open
$167.51
Volume
224,363
Day Range
$162.25 - $170.75
Enterprise Value
4.62B
Cash
155.1M
Avg Qtr Burn
N/A
Insider Ownership
12.27%
Institutional Own.
-
Qtr Updated
09/30/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
